162 related articles for article (PubMed ID: 14576127)
1. Effect of parenteral antibiotic administration on establishment of intestinal colonization in mice by Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.
Hoyen CK; Pultz NJ; Paterson DL; Aron DC; Donskey CJ
Antimicrob Agents Chemother; 2003 Nov; 47(11):3610-2. PubMed ID: 14576127
[TBL] [Abstract][Full Text] [Related]
2. Effects of imipenem-cilastatin, ertapenem, piperacillin-tazobactam, and ceftriaxone treatments on persistence of intestinal colonization by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae strains in mice.
Pultz MJ; Donskey CJ
Antimicrob Agents Chemother; 2007 Aug; 51(8):3044-5. PubMed ID: 17562802
[No Abstract] [Full Text] [Related]
3. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
[TBL] [Abstract][Full Text] [Related]
4. Effect of antibiotic treatment on establishment and elimination of intestinal colonization by KPC-producing Klebsiella pneumoniae in mice.
Perez F; Pultz MJ; Endimiani A; Bonomo RA; Donskey CJ
Antimicrob Agents Chemother; 2011 Jun; 55(6):2585-9. PubMed ID: 21422202
[TBL] [Abstract][Full Text] [Related]
5. Severe sepsis facilitates intestinal colonization by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and transfer of the SHV-18 resistance gene to Escherichia coli during antimicrobial treatment.
Guan J; Liu S; Lin Z; Li W; Liu X; Chen D
Antimicrob Agents Chemother; 2014; 58(2):1039-46. PubMed ID: 24277046
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
[TBL] [Abstract][Full Text] [Related]
7. Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase-producing organisms.
Lan CK; Hsueh PR; Wong WW; Fung CP; Lau YT; Yeung JY; Young GT; Su CC
J Microbiol Immunol Infect; 2003 Sep; 36(3):182-6. PubMed ID: 14582562
[TBL] [Abstract][Full Text] [Related]
8. [Comparative activity of cefepime, ceftazidime and imipenem in a mouse infection caused by Klebsiella pneumoniae producing a broad spectrum beta-lactamase].
Ronco E; Lawrence C; Nauciel C
Pathol Biol (Paris); 1998 Oct; 46(8):651-5. PubMed ID: 9871937
[TBL] [Abstract][Full Text] [Related]
9. In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae.
Burgess DS; Hall RG
Diagn Microbiol Infect Dis; 2004 May; 49(1):41-6. PubMed ID: 15135499
[TBL] [Abstract][Full Text] [Related]
10. Nosocomial liver abscess caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
Lin JC; Siu LK; Fung CP; Yeh KM; Chang FY
J Clin Microbiol; 2007 Jan; 45(1):266-9. PubMed ID: 17093025
[TBL] [Abstract][Full Text] [Related]
11. Duration of stool colonization in patients infected with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Apisarnthanarak A; Bailey TC; Fraser VJ
Clin Infect Dis; 2008 Apr; 46(8):1322-3. PubMed ID: 18444877
[No Abstract] [Full Text] [Related]
12. Effect of parenteral antibiotic administration on establishment of intestinal colonization by Candida glabrata in adult mice.
Pultz NJ; Stiefel U; Ghannoum M; Helfand MS; Donskey CJ
Antimicrob Agents Chemother; 2005 Jan; 49(1):438-40. PubMed ID: 15616330
[TBL] [Abstract][Full Text] [Related]
13. SHV Hyperproduction as a Mechanism for Piperacillin-Tazobactam Resistance in Extended-Spectrum Cephalosporin-Susceptible
Han MS; Park KS; Jeon JH; Lee JK; Lee JH; Choi EH; Lee SH
Microb Drug Resist; 2020 Apr; 26(4):334-340. PubMed ID: 31651221
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology of a citywide outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection.
Quale JM; Landman D; Bradford PA; Visalli M; Ravishankar J; Flores C; Mayorga D; Vangala K; Adedeji A
Clin Infect Dis; 2002 Oct; 35(7):834-41. PubMed ID: 12228820
[TBL] [Abstract][Full Text] [Related]
15. Effects of daptomycin, linezolid, and vancomycin on establishment of intestinal colonization with vancomycin-resistant enterococci and extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae in mice.
Pultz NJ; Stiefel U; Donskey CJ
Antimicrob Agents Chemother; 2005 Aug; 49(8):3513-6. PubMed ID: 16048971
[TBL] [Abstract][Full Text] [Related]
16. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
17. Conjugative resistance to tazobactam plus piperacillin among extended-spectrum beta-lactamase-producing nosocomial Klebsiella pneumoniae.
Akhan S; Coskunkan F; Tansel O; Vahaboglu H
Scand J Infect Dis; 2001; 33(7):512-5. PubMed ID: 11515761
[TBL] [Abstract][Full Text] [Related]
18. [Efficacies of ceftazidime and cefepime in rats with experimental pneumonia caused by extended-spectrum beta-lactamase-producing strain of Klebsiella pneumonia].
Wang WF; Liu YN; She DY
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):390-4. PubMed ID: 17045021
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae.
Harada Y; Morinaga Y; Kaku N; Nakamura S; Uno N; Hasegawa H; Izumikawa K; Kohno S; Yanagihara K
Clin Microbiol Infect; 2014 Nov; 20(11):O831-9. PubMed ID: 24813594
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiological study on extended-spectrum beta-lactamase-producing in clinical isolates and selection of antibacterial drugs in China ].
Yu YS
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1918-20. PubMed ID: 15631810
[No Abstract] [Full Text] [Related]
[Next] [New Search]
